ES2871089T3 - Sistemas y métodos de gestión del tratamiento de la enfermedad de Cushing mediante el seguimiento de síntomas - Google Patents

Sistemas y métodos de gestión del tratamiento de la enfermedad de Cushing mediante el seguimiento de síntomas Download PDF

Info

Publication number
ES2871089T3
ES2871089T3 ES15793415T ES15793415T ES2871089T3 ES 2871089 T3 ES2871089 T3 ES 2871089T3 ES 15793415 T ES15793415 T ES 15793415T ES 15793415 T ES15793415 T ES 15793415T ES 2871089 T3 ES2871089 T3 ES 2871089T3
Authority
ES
Spain
Prior art keywords
patient
facial
images
treatment
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15793415T
Other languages
English (en)
Spanish (es)
Inventor
Steven Lo
David Penake
John Lyons
Lisa Saginian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corcept Therapeutics Inc
Original Assignee
Corcept Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corcept Therapeutics Inc filed Critical Corcept Therapeutics Inc
Application granted granted Critical
Publication of ES2871089T3 publication Critical patent/ES2871089T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1079—Measuring physical dimensions, e.g. size of the entire body or parts thereof using optical or photographic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/492—Determining multiple analytes
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/60—Analysis of geometric attributes
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V40/00—Recognition of biometric, human-related or animal-related patterns in image or video data
    • G06V40/10—Human or animal bodies, e.g. vehicle occupants or pedestrians; Body parts, e.g. hands
    • G06V40/16—Human faces, e.g. facial parts, sketches or expressions
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Theoretical Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ecology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Multimedia (AREA)
  • Human Computer Interaction (AREA)
  • Geometry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Dentistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
ES15793415T 2014-05-16 2015-05-18 Sistemas y métodos de gestión del tratamiento de la enfermedad de Cushing mediante el seguimiento de síntomas Active ES2871089T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461994815P 2014-05-16 2014-05-16
PCT/US2015/031408 WO2015176062A2 (en) 2014-05-16 2015-05-18 Systems and methods of managing treatment of a chronic condition by symptom tracking

Publications (1)

Publication Number Publication Date
ES2871089T3 true ES2871089T3 (es) 2021-10-28

Family

ID=54480946

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15793415T Active ES2871089T3 (es) 2014-05-16 2015-05-18 Sistemas y métodos de gestión del tratamiento de la enfermedad de Cushing mediante el seguimiento de síntomas

Country Status (8)

Country Link
US (2) US9977875B2 (enExample)
EP (1) EP3143494B1 (enExample)
JP (2) JP6712233B2 (enExample)
CN (1) CN106662992A (enExample)
AU (1) AU2015258807B2 (enExample)
CA (1) CA2948575C (enExample)
ES (1) ES2871089T3 (enExample)
WO (1) WO2015176062A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2871089T3 (es) 2014-05-16 2021-10-28 Corcept Therapeutics Inc Sistemas y métodos de gestión del tratamiento de la enfermedad de Cushing mediante el seguimiento de síntomas
US11045134B2 (en) * 2016-01-19 2021-06-29 Washington University Depression brain computer interface for the quantitative assessment of mood state and for biofeedback for mood alteration
US12470894B2 (en) 2016-12-15 2025-11-11 Conquer Your Addiction Llc Systems and methods for proactively preempting/mitigating anxiety-related behaviors and associated issues/events
US11412353B2 (en) 2016-12-15 2022-08-09 Conquer Your Addiction Llc Systems and methods for monitoring for and preempting the risk of a future occurrence of a quarantine violation
US12342240B2 (en) 2016-12-15 2025-06-24 Conquer Your Addiction Llc Systems and methods for monitoring for and lowering the risk of addiction-related or restriction violation-related behavior(s)
US10497242B2 (en) 2016-12-15 2019-12-03 David H. Williams Systems and methods for monitoring for and preempting pre-identified restriction violation-related behavior(s) of persons under restriction
US10853897B2 (en) 2016-12-15 2020-12-01 David H. Williams Systems and methods for developing, monitoring, and enforcing agreements, understandings, and/or contracts
WO2018112048A1 (en) 2016-12-15 2018-06-21 Williams David H Systems and methods for providing location-based security and/or privacy for restricting user access
US11636941B2 (en) 2016-12-15 2023-04-25 Conquer Your Addiction Llc Dynamic and adaptive systems and methods for rewarding and/or disincentivizing behaviors
US12096308B2 (en) 2016-12-15 2024-09-17 Conquer Your Addiction Llc Systems and methods for conducting/defending digital warfare or conflict
JP2021520982A (ja) * 2018-02-19 2021-08-26 ジェイソン ハリソン，ハワード 医療診断用の画像収集および寸法分析のための方法及びシステム
JP7230409B2 (ja) * 2018-10-02 2023-03-01 カシオ計算機株式会社 判定装置、判定方法及び判定プログラム
US11728031B2 (en) 2018-10-12 2023-08-15 Bfc Med Llc Software application for patient care and related device, system, and method
CN110473629A (zh) * 2019-08-22 2019-11-19 南京航空航天大学 一种肾透析治疗方案推荐方法及系统
JP7419720B2 (ja) * 2019-09-24 2024-01-23 カシオ計算機株式会社 画像処理装置、画像処理方法及び画像処理プログラム
CN111493585A (zh) * 2020-04-24 2020-08-07 王晨庄 基于5g智能化的多用途综合远控床医疗体和智能方法
US11504048B2 (en) 2020-06-10 2022-11-22 Medtronic Monitoring, Inc. Triggering arrhythmia episodes for heart failure and chronotropic incompetence diagnosis and monitoring
CN116018652A (zh) * 2020-08-14 2023-04-25 赛诺菲 监测系统
CN112489746B (zh) * 2020-12-08 2024-07-05 深圳平安智慧医健科技有限公司 数据管理的任务推送方法、装置、电子设备及存储介质
KR102510347B1 (ko) * 2021-02-10 2023-03-20 고려대학교 산학협력단 위암 수술 이후 제2형 당뇨병 예후의 예측 방법
US12009103B1 (en) * 2021-03-04 2024-06-11 Edward R Silansky Systems, devices, and/or methods for managing health
JP7135146B1 (ja) 2021-03-26 2022-09-12 エヌ・ティ・ティ・コミュニケーションズ株式会社 投薬対象者管理システム、管理方法、管理制御装置、端末装置およびプログラム
WO2023027853A1 (en) * 2021-08-26 2023-03-02 Hypatia Group, Inc. Health monitoring system with precision eye-blocking filter
US20230381527A1 (en) * 2022-05-31 2023-11-30 West Affum Holdings Dublin DAC Wearable medical system with device parameters and patient information programmable via browser interface
CN117809857B (zh) * 2024-02-29 2024-06-07 广州市品众电子科技有限公司 一种基于人工智能的vr设备运行数据分析方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008210399A (ja) * 1997-03-14 2008-09-11 First Opinion Corp 疾患管理システム
JP2004065822A (ja) 2002-08-09 2004-03-04 Nippon Colin Co Ltd 遠隔診断システム
US20050283385A1 (en) * 2004-06-21 2005-12-22 The Permanente Medical Group, Inc. Individualized healthcare management system
US20060036619A1 (en) * 2004-08-09 2006-02-16 Oren Fuerst Method for accessing and analyzing medically related information from multiple sources collected into one or more databases for deriving illness probability and/or for generating alerts for the detection of emergency events relating to disease management including HIV and SARS, and for syndromic surveillance of infectious disease and for predicting risk of adverse events to one or more drugs
US20080242977A1 (en) 2007-03-30 2008-10-02 General Electric Company Systems, methods and apparatus for longitudinal/temporal analysis of plaque lesions
US10776453B2 (en) * 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US9216221B2 (en) * 2008-11-07 2015-12-22 University Of Sheffield Medicament and method of diagnosis for treating subclinical Cushing's syndrome
JP6367557B2 (ja) * 2011-01-07 2018-08-01 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 臨床データ解析モジュールへの統合的なアクセスおよび臨床データ解析モジュールとの相互作用
CN102063579A (zh) * 2011-01-30 2011-05-18 潘亚萍 牙周电子病历系统及其操作方法
CN102231172A (zh) * 2011-06-10 2011-11-02 王坦 一种远程医疗信息采集系统
US20130006793A1 (en) 2011-06-29 2013-01-03 International Business Machines Corporation Migrating Computing Environment Entitlement Contracts Based on Seller and Buyer Specified Criteria
US10500216B2 (en) 2011-11-18 2019-12-10 Corcept Therapeutics, Inc. Optimizing mifepristone absorption
US9836581B2 (en) * 2012-08-16 2017-12-05 Ginger.io, Inc. Method for modeling behavior and health changes
CN103324853A (zh) * 2013-06-25 2013-09-25 上海交通大学 基于医学图像特征的相似度计算系统及方法
AU2014321267A1 (en) 2013-09-20 2016-05-05 Corcept Therapeutics, Inc. Systems and methods of treatment using intervention and tasking determination
CN103690149B (zh) * 2013-12-30 2016-08-17 惠州Tcl移动通信有限公司 通过面部拍照识别身体健康状况的移动终端及其实现方法
ES2871089T3 (es) 2014-05-16 2021-10-28 Corcept Therapeutics Inc Sistemas y métodos de gestión del tratamiento de la enfermedad de Cushing mediante el seguimiento de síntomas

Also Published As

Publication number Publication date
US20150332020A1 (en) 2015-11-19
JP6712233B2 (ja) 2020-06-17
CN106662992A (zh) 2017-05-10
AU2015258807A1 (en) 2016-11-24
JP2020023573A (ja) 2020-02-13
EP3143494B1 (en) 2021-03-31
CA2948575C (en) 2023-08-08
WO2015176062A2 (en) 2015-11-19
US11610666B2 (en) 2023-03-21
AU2015258807B2 (en) 2018-11-29
EP3143494A2 (en) 2017-03-22
US9977875B2 (en) 2018-05-22
WO2015176062A3 (en) 2015-12-30
EP3143494A4 (en) 2018-01-24
CA2948575A1 (en) 2015-11-19
US20180240544A1 (en) 2018-08-23
JP2017518283A (ja) 2017-07-06

Similar Documents

Publication Publication Date Title
ES2871089T3 (es) Sistemas y métodos de gestión del tratamiento de la enfermedad de Cushing mediante el seguimiento de síntomas
Finnerup et al. Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy
Wong et al. Effects of an immersive virtual reality intervention on pain and anxiety among pediatric patients undergoing venipuncture: a randomized clinical trial
Muggli et al. Association between prenatal alcohol exposure and craniofacial shape of children at 12 months of age
Tait et al. Effect of budesonide added to large-volume, low-pressure saline sinus irrigation for chronic rhinosinusitis: a randomized clinical trial
Papakostas et al. Long-term outcomes after proton beam irradiation in patients with large choroidal melanomas
Rochon et al. Atypical antipsychotics and parkinsonism
Birch et al. Effect of oral valproic acid vs placebo for vision loss in patients with autosomal dominant retinitis pigmentosa: a randomized phase 2 multicenter placebo-controlled clinical trial
Al Thomairy et al. Use of smartphones in hospitals
JP2017518283A5 (enExample)
US20130110551A1 (en) Systems and methods for managing chronic conditions
US20140229191A1 (en) Prescription decision support system and method using comprehensive multiplex drug monitoring
Trindade-Suedam et al. Rapid maxillary expansion increases internal nasal dimensions of children with bilateral cleft lip and palate
Shin et al. Assessment of pupillary light reflex using a smartphone application
Nyer et al. A randomized controlled trial of community-delivered heated hatha yoga for moderate-to-severe depression
Omran et al. Postoperative pain trajectories in total hip arthroplasty: an analysis of patient-reported outcomes
Moustafa et al. Utilizing machine learning to predict post-treatment outcomes in chronic non-specific neck pain patients undergoing cervical extension traction
Rawson et al. Public acceptability of computer-controlled antibiotic management: an exploration of automated dosing and opportunities for implementation
Makatsori et al. Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol
Scott et al. Baseline Characteristics and Outcomes After Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18
David et al. Improving nursing knowledge and patient education about aprepitant's effects on hormonal contraception: A performance improvement project
El Hajj et al. Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial
de la Fuente-Fernández Presynaptic mechanisms of motor complications in Parkinson disease
Dooley et al. “We’ll call you when the results are in”: Preferences for how medical test results are delivered
Overkamp Apps and More: Potentials of Digitalization in Breast Medicine